Annual EBITDA
-$300.99M$72.62M+19.44%
Summary
- Current Value
- As of today, BNTX annual EBITDA is -$300.99M, up +19.44% on
- Historical Performance
- BNTX annual EBITDA is down -101.87% over the past 3 years, down -15.88% over the past 5 years
- All-Time High Comparison
- BNTX annual EBITDA is currently -101.44% below its historical high of $20.93B set on
- 3-Year Low Comparison
- BNTX annual EBITDA is +19.44% above its 3-year low of -$373.62M reached on
- Sector Comparison
- BNTX annual EBITDA is higher than 4.16% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$300.99M | +19.4% | -101.9% | -15.9% | – | |
| Quarterly EBITDA | $573.53M | -35.5% | +346.8% | -89.3% | +3125.5% | |
| TTM EBITDA | -$688.38M | -465.3% | -117.4% | -105.6% | -3531.3% | |
| Price | $81.38 | -19.8% | -18.1% | -71.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $3.24B | +8.8% | -82.2% | +489.1% | – | |
| Annual EPS | -$5.30 | -77.2% | -113.4% | -7710.9% | – | |
| -$733.01M | -5.3% | -104.6% | -141.2% | – | ||
| Annual Net Income | -$1.28B | -78.2% | -112.9% | -7500.6% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $16.10B | N/A | -101.9% |
| 5Y | $20.93B | -101.4% | |
| All | $20.93B | -101.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$373.62M | +19.4% | |
| 5Y | -$373.62M | +19.4% | |
| All | -$373.62M | +19.4% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$300.99M | +19.4% | |
| -$373.62M | -131.7% | |
| $1.18B | -92.7% | |
| $16.10B | -23.1% | |
| $20.93B | +8,159.2% |
| Year | Value | Change |
|---|---|---|
| -$259.75M | -55.1% | |
| -$167.49M | -288.5% | |
| -$43.12M | +27.7% | |
| -$59.61M | - |
FAQ
- What is the current annual EBITDA of BNTX?
- As of today, BNTX annual EBITDA is -$300.99M
- What is 1-year change in BNTX annual EBITDA?
- BNTX annual EBITDA is up +19.44% year-over-year
- What is 3-year change in BNTX annual EBITDA?
- BNTX annual EBITDA is down -101.87% over the past 3 years
- How far is BNTX annual EBITDA from its all-time high?
- BNTX annual EBITDA is currently -101.44% below its historical high of $20.93B set on December 31, 2021
- How does BNTX annual EBITDA rank versus sector peers?
- BNTX annual EBITDA is higher than 4.16% of companies in Healthcare sector
- When is BNTX next annual earnings release?
- The next annual earnings release for BNTX is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$573.53M$1.12B+204.04%
Summary
- Current Value
- As of today, BNTX quarterly EBITDA is $573.53M, up +204.04% on
- Historical Performance
- BNTX quarterly EBITDA is down -35.46% year-over-year, up +346.80% over the past 3 years
- All-Time High Comparison
- BNTX quarterly EBITDA is currently -89.32% below its historical high of $5.37B set on
- 3-Year Low Comparison
- BNTX quarterly EBITDA is +182.01% above its 3-year low of -$699.32M reached on
- Sector Comparison
- BNTX quarterly EBITDA is higher than 95.19% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $573.53M | +204.0% | -35.5% | +346.8% | -89.3% | |
| Annual EBITDA | -$300.99M | – | +19.4% | -101.9% | -15.9% | |
| TTM EBITDA | -$688.38M | -84.4% | -465.3% | -117.4% | -105.6% | |
| Price | $81.38 | -28.1% | -19.8% | -18.1% | -71.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.48B | +1108.0% | -16.4% | +52.3% | -79.3% | |
| Quarterly EPS | $0.84 | +122.1% | +702.1% | +15.2% | -94.2% | |
| $191.22M | +122.2% | -74.3% | +129.2% | -96.4% | ||
| Quarterly Net Income | $212.27M | +122.2% | +732.9% | +21.5% | -94.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $888.62M | N/A | -35.5% |
| 3Y | $888.62M | -35.5% | |
| 5Y | $5.37B | N/A | -89.3% |
| All | $5.37B | -89.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$631.53M | +190.8% | |
| 3Y | -$699.32M | +182.0% | |
| 5Y | -$699.32M | +182.0% | |
| All | -$699.32M | +182.0% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of BNTX?
- As of today, BNTX quarterly EBITDA is $573.53M
- What is BNTX quarterly EBITDA most recent change?
- BNTX quarterly EBITDA was up +204.04% on September 30, 2026
- What is 1-year change in BNTX quarterly EBITDA?
- BNTX quarterly EBITDA is down -35.46% year-over-year
- How far is BNTX quarterly EBITDA from its all-time high?
- BNTX quarterly EBITDA is currently -89.32% below its historical high of $5.37B set on September 30, 2021
- How does BNTX quarterly EBITDA rank versus sector peers?
- BNTX quarterly EBITDA is higher than 95.19% of companies in Healthcare sector
- When is BNTX next earnings release?
- The next earnings release for BNTX is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$688.38M$315.09M-84.41%
Summary
- Current Value
- As of today, BNTX TTM EBITDA is -$688.38M, down -84.41% on
- Historical Performance
- BNTX TTM EBITDA is down -465.28% year-over-year, down -117.40% over the past 3 years
- All-Time High Comparison
- BNTX TTM EBITDA is currently -103.29% below its historical high of $20.91B set on
- 3-Year Low Comparison
- BNTX TTM EBITDA is at its 3-year low
- Sector Comparison
- BNTX TTM EBITDA is higher than 0.67% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$688.38M | -84.4% | -465.3% | -117.4% | -105.6% | |
| Annual EBITDA | -$300.99M | – | +19.4% | -101.9% | -15.9% | |
| Quarterly EBITDA | $573.53M | +204.0% | -35.5% | +346.8% | -89.3% | |
| Price | $81.38 | -28.1% | -19.8% | -18.1% | -71.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $2.80B | -9.4% | -20.7% | -59.4% | -83.0% | |
| TTM EPS | -$6.87 | +12.5% | -161.2% | -159.7% | -119.8% | |
| -$1.71B | -47.5% | -626.3% | -144.9% | -114.0% | ||
| TTM Net Income | -$1.72B | +12.5% | -171.8% | -160.7% | -119.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $188.45M | N/A | -465.3% |
| 3Y | $3.96B | N/A | -117.4% |
| 5Y | $20.91B | -103.3% | |
| All | $20.91B | -103.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$688.38M | at low | |
| 3Y | -$688.38M | at low | |
| 5Y | -$688.38M | at low | |
| All | -$688.38M | at low |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of BNTX?
- As of today, BNTX TTM EBITDA is -$688.38M
- What is BNTX TTM EBITDA most recent change?
- BNTX TTM EBITDA was down -84.41% on September 30, 2026
- What is 1-year change in BNTX TTM EBITDA?
- BNTX TTM EBITDA is down -465.28% year-over-year
- How far is BNTX TTM EBITDA from its all-time high?
- BNTX TTM EBITDA is currently -103.29% below its historical high of $20.91B set on March 31, 2022
- How does BNTX TTM EBITDA rank versus sector peers?
- BNTX TTM EBITDA is higher than 0.67% of companies in Healthcare sector
- When is BNTX next earnings release?
- The next earnings release for BNTX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- BNTX Official Website www.biontech.de
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1776985/000177698526000017/0001776985-26-000017-index.htm
- BNTX Profile on Yahoo Finance finance.yahoo.com/quote/BNTX
- BNTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bntx
